Acasti Pharma, Inc.Acasti Pharma, Inc.Acasti Pharma, Inc.

Acasti Pharma, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪25.57 M‬USD
−5.09USD
‪−42.43 M‬USD
‪6.75 M‬
Beta (1Y)
0.00

About Acasti Pharma, Inc.

CEO
Prashant Kohli
Headquarters
Princeton
Website
Founded
2002
FIGI
BBG001NMDXS6
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ACST is 2.72 USD — it has increased by 2.64% in the past 24 hours. Watch Acasti Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Acasti Pharma, Inc. stocks are traded under the ticker ACST.
ACST stock hasn't changed in a week, the month change is a 5.26% fall, over the last year Acasti Pharma, Inc. has showed a 12.80% decrease.
We've gathered analysts' opinions on Acasti Pharma, Inc. future price: according to them, ACST price has a max estimate of 6.00 USD and a min estimate of 6.00 USD. Watch ACST chart and read a more detailed Acasti Pharma, Inc. stock forecast: see what analysts think of Acasti Pharma, Inc. and suggest that you do with its stocks.
ACST reached its all-time high on Jul 24, 2013 with the price of 2015.60 USD, and its all-time low was 1.72 USD and was reached on Sep 22, 2023. View more price dynamics on ACST chart.
See other stocks reaching their highest and lowest prices.
ACST stock is 4.56% volatile and has beta coefficient of 0.00. Track Acasti Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Acasti Pharma, Inc. there?
Today Acasti Pharma, Inc. has the market capitalization of ‪25.57 M‬, it has increased by 10.45% over the last week.
Yes, you can track Acasti Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
Acasti Pharma, Inc. is going to release the next earnings report on Jun 18, 2024. Keep track of upcoming events with our Earnings Calendar.
ACST earnings for the last quarter are −0.21 USD per share, whereas the estimation was −0.23 USD resulting in a 8.70% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Acasti Pharma, Inc. earnings.
Acasti Pharma, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 0 USD.
ACST net income for the last quarter is ‪−2.39 M‬ USD, while the quarter before that showed ‪−3.27 M‬ USD of net income which accounts for 26.95% change. Track more Acasti Pharma, Inc. financial stats to get the full picture.
No, ACST doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acasti Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Acasti Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Acasti Pharma, Inc. stock shows the sell signal. See more of Acasti Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.